News
DGX
206.26
+1.90%
3.85
Weekly Report: what happened at DGX last week (0216-0220)?
Weekly Report · 7h ago
Here are the major earnings after the close Thursday
Seeking Alpha · 4d ago
Dividend picks: 20 large-cap defensive stocks outperforming the market in 2026
Seeking Alpha · 5d ago
Do Wall Street Analysts Like Quest Diagnostics Stock?
Barchart · 5d ago
Labcorp guidance ‘should be well received,’ says Morgan Stanley
TipRanks · 5d ago
Evaluating Quest Diagnostics (DGX) After Dividend Hike Strong Earnings Guidance And Expanded Buyback
Simply Wall St · 6d ago
Weekly Report: what happened at DGX last week (0209-0213)?
Weekly Report · 02/16 09:59
Notable healthcare headlines for the week: AstraZeneca, CVS Health, and Moderna in focus
Seeking Alpha · 02/15 14:05
Quest Diagnostics (DGX) Is Up 8.5% After Strong 2026 Guidance And New Myeloma Test Launch - Has The Bull Case Changed?
Simply Wall St · 02/15 12:33
Walmart To Lead Group Of 11 Companies Announcing Annual Dividend Increases In Second Half Of February
Seeking Alpha · 02/15 03:16
Dividend Champion, Contender, And Challenger Highlights: Week Of February 15
Seeking Alpha · 02/13 23:33
Dividend Roundup: Chevron, Microsoft, Meta, Hyatt, and more
Seeking Alpha · 02/13 14:04
Quest Diagnostics MRD Blood Test May Support Growth In Higher Value Oncology
Simply Wall St · 02/12 17:34
Quest Diagnostics Is Maintained at Outperform by Mizuho
Dow Jones · 02/12 13:34
Mizuho Maintains Outperform on Quest Diagnostics, Raises Price Target to $235
Benzinga · 02/12 13:23
Quest Diagnostics price target raised to $235 from $210 at Mizuho
TipRanks · 02/12 12:41
Analysts Are Bullish on These Healthcare Stocks: Doximity (DOCS), Quest Diagnostics (DGX)
TipRanks · 02/12 01:20
Forecasting The Future: 6 Analyst Projections For Quest Diagnostics
Benzinga · 02/11 22:00
Quest Diagnostics Is Maintained at Hold by Truist Securities
Dow Jones · 02/11 16:48
Quest Diagnostics Price Target Raised to $220.00/Share From $205.00 by Truist Securities
Dow Jones · 02/11 16:48
More
Webull provides a variety of real-time DGX stock news. You can receive the latest news about Quest Diagnostics Inc through multiple platforms. This information may help you make smarter investment decisions.
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.